Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (81-90 of 397) with videos related to

Pageof 40
Sort By:
Plos One|December 11, 2019
HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San FranciscoKimberly Page, Jennifer L Evans, Judith A Hahn, et al.
The International Journal on Drug Policy|October 28, 2016
Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of EnglandJoanna M Kesten, Rachel Ayres, Jane Neale, et al.
The International Journal on Drug Policy|March 4, 2017
Rejoinder to: Implementation of low dead space syringes in response to an outbreak of HIV among people who inject drugs: A response to Kesten et alJoanna M Kesten, Rachel Ayres, Jane Neale, et al.
Plos One|September 10, 2014
The costs of scaling up HIV prevention for high risk groups: lessons learned from the Avahan Programme in IndiaSudhashree Chandrashekar, Lorna Guinness, Michael Pickles, et al.
The Lancet. Public Health|January 11, 2022
The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling studyJack Stone, Adelina Artenie, Matthew Hickman, et al.
Drug and Alcohol Dependence|March 29, 2022
Modeling the impact of interventions during an outbreak of HIV infection among people who inject drugs in 2012-2013 in Athens, GreeceEleni Flountzi, Aaron G Lim, Peter Vickerman, et al.
Addiction (Abingdon, England)|June 14, 2020
Response to Commentary on Hancock et al. (2020): Low dead space syringes are just one component of an integrated package of care needed to tackle HCV and social exclusion among people who inject drugsJoanna Kesten, Zoe Ward, Elizabeth Hancock, et al.
Addiction (Abingdon, England)|December 9, 2004
The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, BelarusLilani Kumaranayake, Peter Vickerman, Damian Walker, et al.
BMC Public Health|July 26, 2019
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South AfricaChih-Yuan Cheng, Matthew Quaife, Robyn Eakle, et al.
Journal of Hepatology|December 15, 2010
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utilityNatasha K Martin, Peter Vickerman, Graham R Foster, et al.
Pageof 40

Showing results (81-90 of 397) with videos related to

Sort By:
Pageof 40
Plos One|December 11, 2019
HCV incidence is associated with injecting partner age and HCV serostatus mixing in young adults who inject drugs in San FranciscoKimberly Page, Jennifer L Evans, Judith A Hahn, et al.
The International Journal on Drug Policy|October 28, 2016
Acceptability of low dead space syringes and implications for their introduction: A qualitative study in the West of EnglandJoanna M Kesten, Rachel Ayres, Jane Neale, et al.
The International Journal on Drug Policy|March 4, 2017
Rejoinder to: Implementation of low dead space syringes in response to an outbreak of HIV among people who inject drugs: A response to Kesten et alJoanna M Kesten, Rachel Ayres, Jane Neale, et al.
Plos One|September 10, 2014
The costs of scaling up HIV prevention for high risk groups: lessons learned from the Avahan Programme in IndiaSudhashree Chandrashekar, Lorna Guinness, Michael Pickles, et al.
The Lancet. Public Health|January 11, 2022
The contribution of unstable housing to HIV and hepatitis C virus transmission among people who inject drugs globally, regionally, and at country level: a modelling studyJack Stone, Adelina Artenie, Matthew Hickman, et al.
Drug and Alcohol Dependence|March 29, 2022
Modeling the impact of interventions during an outbreak of HIV infection among people who inject drugs in 2012-2013 in Athens, GreeceEleni Flountzi, Aaron G Lim, Peter Vickerman, et al.
Addiction (Abingdon, England)|June 14, 2020
Response to Commentary on Hancock et al. (2020): Low dead space syringes are just one component of an integrated package of care needed to tackle HCV and social exclusion among people who inject drugsJoanna Kesten, Zoe Ward, Elizabeth Hancock, et al.
Addiction (Abingdon, England)|December 9, 2004
The cost-effectiveness of HIV preventive measures among injecting drug users in Svetlogorsk, BelarusLilani Kumaranayake, Peter Vickerman, Damian Walker, et al.
BMC Public Health|July 26, 2019
Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South AfricaChih-Yuan Cheng, Matthew Quaife, Robyn Eakle, et al.
Journal of Hepatology|December 15, 2010
Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utilityNatasha K Martin, Peter Vickerman, Graham R Foster, et al.
Pageof 40